Samsung Biologics CEO John Rim speaks during the 42nd annual J.P. Morgan Healthcare Conference at the main Grand Ballroom in the Westin St. Francis Hotel in San Francisco, California. [SAMSUNG ...

Third from left, Samsung Biologics Executive VIce President Kim Dong-joong, BSI Korea CEO Lim Seong-hwan and Samsung Biologics Executive Vice President Lee Kyu-ho pose for a photo with ISO ...

South Korean contract development and manufacturing organisation (CDMO) Samsung Biologics marks another contract milestone as the company announces two high-value deals totalling £897 million ...

Bristol-Myers Squibb has announced a 10-year manufacturing agreement with Korea-based Samsung BioLogics. Financial terms were not disclosed. Under terms of the agreement, Samsung BioLogics will ...

Korean biopharmaceutical firms warn of potential U.S. tariff and FDA approval delays Biotech industry voices anxiety over U.S ...

Last year, both Samsung Biologics and Celltrion recorded their highest sales in history, with the average salary per employee surpassing 100 million won. This marks the first time that the average ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

AI-powered stock picks with a proven track record to beat the S&P 500.